Global Home Infusion Therapy Market Size, Share And Trends Analysis Report 2030
The global home infusion therapy market size is expected to reach USD 61.7 billion by 2030, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 8.0% from 2023 to 2030. Home infusion therapy involves the intravenous or subcutaneous administration of drugs or biologicals to an individual at home. Favorable government policies and regulations are expected to propel market growth. In February 2018, the Bipartisan Budget Act of 2018 was signed into a law that states that all temporary payments of home infusion therapy in the U.S. will be covered by the government in accordance with this regulation.
Request a free sample copy or view report summary: https://www.grandviewresearch.com/industry-analysis/home-infusion-therapy-market
In addition, the rising prevalence of chronic diseases, such as cardiovascular diseases (CVDs), cancer, diabetes, and other life-threatening conditions, is expected to have a high impact on the market growth. According to a WHO report, the above-mentioned diseases accounted for 60.0% of the total deaths and 43.0% of the disease burden in the U.S. in 2019. This creates the need to infuse nutritional products that contain glutamine, phospholipids, glucose, and amino acids while administering medication to patients, which, in turn, is expected to boost the market growth in this region.
The ongoing COVID-19 pandemic is expected to create lucrative opportunities for the market. Due to the restrictions caused by COVID-19, patients are waiting to seek treatment until they feel safe. Moreover, patients who seek infusion therapy already have diseases, which eventually weaken their immune systems. In such cases, going outside even to receive treatment becomes a potential threat. Reduced operating hours have led to difficulty in scheduling appointments as well, even if patients choose to continue treatment. Hence, home infusion therapy is expected to play a key role in supporting patients.
Home Infusion Therapy Market Report Highlights
- By product, infusion pump emerged as the largest segment in 2022 owing to the increasing use of delivery fluids such as nutrients and medications
- The anti-infective application segment dominated the market in 2022 as a large number of procedures are performed during the administration of medications, such as antibiotics and antifungals
- North America dominated the global market in 2022 owing to the increasing demand for new technologies, along with advanced healthcare infrastructure
- The Asia Pacific market is projected to witness the fastest growth over the forecast period owing to the increasing number of diabetic patients in the region
Home Infusion Therapy Market Segmentation
Grand View Research has segmented the global home infusion therapy market on the basis of product, application, and region:
Home Infusion Therapy Product Outlook (Revenue, USD Million, 2017 - 2030)
- Infusion Pumps
- Elastomeric Pumps
- Electromechanical
- Gravity
- Others
- Intravenous Sets
- IV Cannulas
- Needleless Connectors
Home Infusion Therapy Application Outlook (Revenue, USD Million, 2017 - 2030)
- Anti-infective
- Endocrinology
- Diabetes
- Others
- Hydration Therapy
- Athletes
- Others
- Chemotherapy
- Enteral Nutrition
- Parenteral Nutrition
- Specialty Pharmaceuticals
- Others
Home Infusion Therapy Route of Administration Outlook (Revenue, USD Million, 2017 - 2030)
- Intramuscular
- Subcutaneously
- Epidural
Regional Insights
North America dominated the market in 2022 with a revenue share of over 56.5% and this trend is expected to continue throughout the forecast period. This can be attributed to the increasing R&D in the region and the rising adoption of new technology in infusion pumps. The increasing need for long-term therapy for patients with certain conditions is driving the regional market. Development of alternate healthcare settings and home infusion services and shifting preference from acute care to home care settings due to the low cost and enhanced patient mobility would boost the growth of this market in the coming years.
The Asia Pacific market is expected to register the fastest CAGR of 9.9% over the forecast period. This is attributed to rising patient awareness regarding the benefits of home infusion therapy over in-hospital procedures and the growing prevalence of diabetes in the region. The growing geriatric population and the rise in chronic diseases in the region are expected to further fuel the market growth. According to the Times of India, around 75 million people over the age of 60 years suffer from some chronic disease in India, which might increase the adoption of home care services in the country.
List of Key Players of Home Infusion Therapy Market
- CVS/Coram
- Option Care Health
- CareFusion Corporation
- BriovaRx/Diplomat (UnitedHealth Optum)
- PharMerica
- Fresenius Kabi
- ICU Medical, Inc.
- Braun Melsungen AG
- Baxter
- BD
- Caesarea Medical Electronics
- Smiths Medical
- Terumo Corporation
- JMS Co. Ltd.
Browse Full Report: https://www.grandviewresearch.com/industry-analysis/home-infusion-therapy-market
Comments
Post a Comment